Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Eur J Surg Oncol. 2023 Nov 8;50(1):107252. doi: 10.1016/j.ejso.2023.107252

Table 5.

Comparison between baseline characteristics of MILR in 2361 cirrhosis patients with and without portal hypertension ()

Entire unmatched cohort 1:1 PSM (nearest neighbour matching) 1:1 CEM

All (N = 2327) Cirrhosis PHT (N = 626) Cirrhosis NPHT (N = 1701) P-value Cirrhosis PHT (N = 450) Cirrhosis NPHT (N = 450) P-value Cirrhosis PHT (N = 290) Cirrhosis NPHT (N = 290) P-value (paired)

Median age (IQR), yrs 63.00 [55.00, 71.00] 63.00 [55.00, 71.00] 63.00 [55.00, 71.00] 0.734 62.00 [54.00, 70.00] 64.00 [55.00, 70.00] 0.217 61.00 [54.00, 69.00] 62.00 [55.00, 69.00] 0.607

Male sex, n (%) 1731 (74.4) 468 (74.8) 1263 (74.3) 0.844 339 (75.3) 335 (74.4) 0.822 230 (79.3) 230 (79.3) NA

Median BMI (IQR) 24.68 [22.22, 27.45] 25.08 [22.84, 28.00] 24.50 [22.10, 27.25] <0.001 24.93 [22.50, 27.70] 25.00 [22.49, 27.68] 0.826 24.80 [22.70, 27.40] 24.34 [22.16, 27.24] 0.426

Robotic, n (%) 260 (11.2) 56 (8.9) 204 (12.0) 43 (9.6) 41 (9.1) 12 (4.1) 12 (4.1)
Laparoscopic, n (%) 2067 (88.8) 570 (91.1) 1497 (88.0) 0.046 407 (90.4) 409 (90.9) 0.907 278 (95.9) 278 (95.9) NA

Previous abdominal surgery, n (%) 436 (19.7) 142 (22.7) 294 (18.5) 0.028 98 (21.8) 97 (21.6) 1.000 36 (12.4) 36 (12.4) NA

Childs A, n (%) 2082 (89.5) 1581 (92.9) 501 (80.0) 392 (87.1) 398 (88.4) 280 (96.6) 280 (96.6)
Childs B, n (%) 245 (10.5) 120 (7.1) 125 (20.0) 0.028 58 (12.9) 52 (11.6) 0.561 10 (3.4) 10 (3.4) NA

Year of surgery, n (%)
2004–2009 144 (6.2) 48 (7.7) 96 (5.6) 33 (7.3) 37 (8.2) 10 (3.4) 10 (3.4)
2010–2015 692 (29.7) 173 (27.6) 519 (30.5) 121 (26.9) 118 (26.2) 92 (31.7) 92 (31.7)
2016–2021 1491 (64.1) 405 (64.7) 1086 (63.8) 0.113 296 (65.8) 295 (65.6) 0.939 188 (64.8) 188 (64.8) NA

ASA score, n (%)
 1/2 1604 (69.0) 393 (62.8) 1211 (71.3) 298 (66.2) 297 (66.0) 205 (70.7) 205 (70.7)
 3/4 721 (31.0) 233 (37.2) 488 (28.7) <0.001 152 (33.8) 153 (34.0) 1.000 85 (29.3) 85 (29.3) NA

Tumor type, n (%)
 HCC 2194 (94.3) 613 (97.9) 1581 (93.0) 441 (98.0) 440 (97.8) 288 (99.3) 288 (99.3)
 ICC/ cholangiohepatoma 132 (5.7) 13 (2.1) 119 (7.0) <0.001 9 (2.0) 10 (2.2) 1.000 2 (0.7) 2 (0.7) NA

Median tumor size, mm (IQR) 26.00 [20.00, 38.00] 25.00 [18.00, 35.00] 27.00 [20.00, 40.00] <0.001 25.00 [18.00, 35.00] 25.00 [20.00, 35.00] 0.620 23.50 [18.00, 32.00] 25.00 [19.25, 30.00] 0.748

Multiple tumors, n (%) 228 (9.8) 50 (8.0) 178 (10.5) 0.088 35 (7.8) 32 (7.1) 0.807 4 (1.4) 4 (1.4) NA

Wedge/ partial liver resection, n (%) 1420 (61.0) 410 (65.5) 1010 (59.4) 291 (64.7) 293 (65.1) 199 (68.6) 199 (68.6)
Segmentectomy, n (%) 907 (39.0) 216 (34.5) 691 (40.6) 0.008 159 (35.3) 157 (34.9) 0.942 91 (31.4) 91 (31.4) NA

Concomitant minor surgery excluding cholecystectomy, n (%) 95 (4.1) 31 (5.0) 64 (3.8) 0.242 22 (4.9) 21 (4.7) 1.000 5 (1.7) 5 (1.7) NA

Hilar lymph node dissection, n (%) 9 (0.4) 5 (0.8) 4 (0.2) 0.065 0 (0.0) 1 (0.2) 1.000 0 (0.0) 0 (0.0) NA

Median Iwate difficulty score, [IQR] (range) 4.00 [3.00, 6.00] (1, 9) 4.00 [2.00, 6.00] (1, 9) 4.00 [3.00, 6.00] (1, 9) 0.008 3.00 [2.00, 6.00] (1, 8) 3.00 [2.00, 5.00] (1, 9) 0.704 3.00 [2.00, 5.00] (1, 9) 3.00 [2.00, 5.00] (1, 9) NA

Iwate difficulty, n (%)
 Low 1097 (47.2) 309 (49.4) 788 (46.4) 232 (51.6) 233 (51.8) 169 (58.3) 169 (58.3)
 Intermediate 841 (36.2) 236 (37.7) 605 (35.6) 152 (33.8) 164 (36.4) 97 (33.4) 97 (33.4)
 High 388 (16.7) 81 (12.9) 307 (18.1) 0.013 66 (14.7) 53 (11.8) 0.533 24 (8.3) 24 (8.3) NA